Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Naparstek

Showing results (31-40 of 133) with videos related to

Pageof 14
Sort By:
Bone Marrow Transplantation|March 1, 1988
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT)E Kedar, R Or, E Naparstek, et al.
Bone Marrow Transplantation|September 1, 1990
The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?S Slavin, A Ackerstein, E Naparstek, et al.
British Journal of Haematology|October 1, 1983
Serum transcobalamin levels as an early indicator of bone marrow engraftment following transplantationE Naparstek, B Rachmilewitz, M Rachmilewitz, et al.
Experimental Hematology|September 29, 2000
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantationA Nagler, R Or, E Naparstek, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1989
Osteogenic response to marrow aspiration: increased serum osteocalcin and alkaline phosphatase in human bone marrow donorsJ Foldes, E Naparstek, M Statter, et al.
Experimental Hematology|November 7, 2000
Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantationA Nagler, A Ackerstein, R Or, et al.
Blood|June 1, 1997
Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantationA Nagler, A Ackerstein, R Or, et al.
Clinical Transplants|January 1, 1996
Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignanciesE Naparstek, A Nagler, R Or, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1997
Noncardiogenic pulmonary congestion following bone marrow transplantationR Or, A Nagler, S Elad, et al.
Archives of Internal Medicine|February 1, 1978
Acute lymphoblastic leukemia. Its occurrence with hypereosinophilic syndrome' and bilateral spontaneous pneumothoraxD Geltner, G Friedman, E Naparstek, et al.
Pageof 14

Showing results (31-40 of 133) with videos related to

Sort By:
Pageof 14
Bone Marrow Transplantation|March 1, 1988
Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT)E Kedar, R Or, E Naparstek, et al.
Bone Marrow Transplantation|September 1, 1990
The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?S Slavin, A Ackerstein, E Naparstek, et al.
British Journal of Haematology|October 1, 1983
Serum transcobalamin levels as an early indicator of bone marrow engraftment following transplantationE Naparstek, B Rachmilewitz, M Rachmilewitz, et al.
Experimental Hematology|September 29, 2000
Second allogeneic stem cell transplantation using nonmyeloablative conditioning for patients who relapsed or developed secondary malignancies following autologous transplantationA Nagler, R Or, E Naparstek, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1989
Osteogenic response to marrow aspiration: increased serum osteocalcin and alkaline phosphatase in human bone marrow donorsJ Foldes, E Naparstek, M Statter, et al.
Experimental Hematology|November 7, 2000
Adoptive immunotherapy with haploidentical allogeneic peripheral blood lymphocytes following autologous bone marrow transplantationA Nagler, A Ackerstein, R Or, et al.
Blood|June 1, 1997
Immunotherapy with recombinant human interleukin-2 and recombinant interferon-alpha in lymphoma patients postautologous marrow or stem cell transplantationA Nagler, A Ackerstein, R Or, et al.
Clinical Transplants|January 1, 1996
Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignanciesE Naparstek, A Nagler, R Or, et al.
Respiration; International Review of Thoracic Diseases|January 1, 1997
Noncardiogenic pulmonary congestion following bone marrow transplantationR Or, A Nagler, S Elad, et al.
Archives of Internal Medicine|February 1, 1978
Acute lymphoblastic leukemia. Its occurrence with hypereosinophilic syndrome' and bilateral spontaneous pneumothoraxD Geltner, G Friedman, E Naparstek, et al.
Pageof 14